Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;6(3):164-79.
doi: 10.1016/j.cmet.2007.07.001.

Genetic and genomic insights into the molecular basis of atherosclerosis

Affiliations
Review

Genetic and genomic insights into the molecular basis of atherosclerosis

Yaoyu Chen et al. Cell Metab. 2007 Sep.

Abstract

Atherosclerosis is a complex disease involving genetic and environmental risk factors, acting on their own or in synergy. Within the general population, polymorphisms within genes in lipid metabolism, inflammation, and thrombogenesis are probably responsible for the wide range of susceptibility to myocardial infarction, a fatal consequence of atherosclerosis. Genetic linkage studies have been carried out in both humans and mouse models to identify these polymorphisms. Approximately 40 quantitative trait loci for atherosclerotic disease have been found in humans, and approximately 30 in mice. Recently, genome-wide association studies have been used to identify atherosclerosis-susceptibility polymorphisms. Although discovering new atherosclerosis genes through these approaches remains challenging, the pace at which these polymorphisms are being found is accelerating due to rapidly improving bioinformatics resources and biotechnologies. The outcome of these efforts will not only unveil the molecular basis of atherosclerosis but also facilitate the discovery of drug targets and individualized medication against the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chromosome map of human and mouse concordant QTLs for atherosclerotic diseases. Human HDL-C QTLs are represented by bars to the left of each chromosome. Each bar represents a QTL from one population as shown in Table 1. QTL sizes are given either as 1.5-LOD drop intervals (if LOD score figures are available), or ± 15 cM centered around the LOD score peak (when LOD score figures are unavailable). Human homologues of mouse HDL-C QTLs are represented by red bars to the right of each chromosome, and the chromosome numbers of these mouse QTLs are to their right.
Figure 2
Figure 2
Chromosome map of mouse and human concordant atherosclerosis QTLs. A vertical black line represents each chromosome, with the centromere at the top. Genetic distances in Mb from the centromere are shown by the scale at the lower left of the figure. Mouse atherosclerosis QTLs are represented by bars to the left of each chromosome. Each bar represents a QTL from one cross as shown in Table 2. QTL sizes are given either as 95% confidence intervals (CIs), 1.5-LOD drop intervals (if 95% CIs are not available but LOD score figures are available), or ± 10 cM centered around the LOD score peak (when neither CIs nor LOD score figures are available). To change cM into Mb, we found MIT markers at the cM positions in MGI (informatics.jax.org) and retrieved their Mb positions in Ensembl Mouse Genome Server NCBI m36. Mouse homologues of human HDL-C QTLs are represented by red bars to the right of each chromosome, and the chromosome numbers of these human QTLs are to their right.

Similar articles

Cited by

References

    1. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol. 2002;22:443–449. - PubMed
    1. Altshuler D, Hirschhorn JN. MEF2A sequence variants and coronary artery disease: a change of heart? J Clin Invest. 2005;115:831–833. - PMC - PubMed
    1. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007;115:2878–2901. - PubMed
    1. Bhagavatula MR, Fan C, Shen GQ, Cassano J, Plow EF, Topol EJ, Wang Q. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet. 2004;13:3181–3188. - PMC - PubMed
    1. Bretschger Seidelmann S, De Luca C, Leibel RL, Breslow JL, Tall AR, Welch CL. Quantitative Trait Locus Mapping of Genetic Modifiers of Metabolic Syndrome and Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Identification of a Locus for Metabolic Syndrome and Increased Atherosclerosis on Chromosome 4. Arterioscler Thromb Vasc Biol. 2005;25:1–8. - PMC - PubMed

Publication types

Substances